PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsStroke
MeSH D020521 - stroke
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D002561:Cerebrovascular disorders
0 Companies
0 Drugs
Success rate
D020521: 
Stroke
$
Success rate
D000083242:Ischemic stroke
0 Companies
0 Drugs
Success rate
D000083302:Hemorrhagic stroke
0 Companies
0 Drugs
Success rate
D020520:Brain infarction
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaClopidogrel Clopidogrel Teva (hydrogen sulphate)  2009-07-27   
Clopidogrel Clopidogrel Teva Pharma (previously Clopidogrel HCS)  2009-09-21   
Clopidogrel Clopidogrel ratiopharm  2015-02-18   
Clopidogrel Clopidogrel Teva Generics B.V  2010-10-28   
Clopidogrel Clopidogrel Teva Pharma B.V  2011-06-16   
Taro PharmaceuticalWarfarin Warfarin  1999-07-15   
MylanClopidogrel Clopidogrel DURA  2009-07-21   
Rivaroxaban Rivaroxaban Viatris (previously Rivaroxaban Mylan)  2021-11-12   
CiplaWarfarin Warfarin  2011-05-25   
SanofiClopidogrel Iscover  1998-07-14   
Clopidogrel Plavix  1998-07-15   
Barr PharmaceuticalsWarfarin Warfarin  1997-03-26   
Zydus TherapeuticsWarfarin Warfarin  2006-05-30   
1
2
3
>
Clinical Trials
Historical Success Rate
Phase 1
73%
35/48
Phase 2
59%
66/112
Phase 3
54%
64/119
Approved: 7Overall Success rate: 23%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
1
2
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use